Compromised HOXA5 function can limit p53 expression in human breast tumours

Venu Raman, Shelby A. Martenser, David Reisman, Ella Evron, Wart F. Odenwald, Elizabeth Jaffee, Jeffrey Marks, Saraswati Sukumar

Research output: Contribution to journalArticle

Abstract

Expression of the p55 gene protects cells against malignant transformation. Whereas control of p53 degradation has been a subject of intense scrutiny, little is known about the factors that regulate p53 synthesis. Here we show that p53 messenger RNA levels are low in a large proportion of breast tumours. Seeking potential regulators of p53 transcription, we found consensus HOX binding sites in the p53 promoter. Transient transfection of Hox/HOXA5 activated the p53 promoter. Expression of HOXA5 in epithelial cancer cells expressing wild-type p53, but not in isogenic variants lacking the p53 gene, led to apoptotic cell death. Moreover, breast cancer cell lines and patient tumours display a coordinate loss of p53 and HOXA5 mRNA and protein expression. The HOXA5 promoter region was methylated in 16 out of 20 p53-negative breast tumour specimens. We conclude that loss of expression of p53 in human breast cancer may be primarily due to lack of expression of HOXA5.

Original languageEnglish (US)
Pages (from-to)974-978
Number of pages5
JournalNature
Volume405
Issue number6789
DOIs
StatePublished - Jun 22 2000

Fingerprint

Breast Neoplasms
Messenger RNA
p53 Genes
Tumor Cell Line
Genetic Promoter Regions
Transfection
Cell Death
Epithelial Cells
Binding Sites
Gene Expression
Neoplasms
Proteins

ASJC Scopus subject areas

  • General

Cite this

Compromised HOXA5 function can limit p53 expression in human breast tumours. / Raman, Venu; Martenser, Shelby A.; Reisman, David; Evron, Ella; Odenwald, Wart F.; Jaffee, Elizabeth; Marks, Jeffrey; Sukumar, Saraswati.

In: Nature, Vol. 405, No. 6789, 22.06.2000, p. 974-978.

Research output: Contribution to journalArticle

Raman, V, Martenser, SA, Reisman, D, Evron, E, Odenwald, WF, Jaffee, E, Marks, J & Sukumar, S 2000, 'Compromised HOXA5 function can limit p53 expression in human breast tumours', Nature, vol. 405, no. 6789, pp. 974-978. https://doi.org/10.1038/35016125
Raman V, Martenser SA, Reisman D, Evron E, Odenwald WF, Jaffee E et al. Compromised HOXA5 function can limit p53 expression in human breast tumours. Nature. 2000 Jun 22;405(6789):974-978. https://doi.org/10.1038/35016125
Raman, Venu ; Martenser, Shelby A. ; Reisman, David ; Evron, Ella ; Odenwald, Wart F. ; Jaffee, Elizabeth ; Marks, Jeffrey ; Sukumar, Saraswati. / Compromised HOXA5 function can limit p53 expression in human breast tumours. In: Nature. 2000 ; Vol. 405, No. 6789. pp. 974-978.
@article{22bb7a3b51bb470eb1a5796ce63b4f9c,
title = "Compromised HOXA5 function can limit p53 expression in human breast tumours",
abstract = "Expression of the p55 gene protects cells against malignant transformation. Whereas control of p53 degradation has been a subject of intense scrutiny, little is known about the factors that regulate p53 synthesis. Here we show that p53 messenger RNA levels are low in a large proportion of breast tumours. Seeking potential regulators of p53 transcription, we found consensus HOX binding sites in the p53 promoter. Transient transfection of Hox/HOXA5 activated the p53 promoter. Expression of HOXA5 in epithelial cancer cells expressing wild-type p53, but not in isogenic variants lacking the p53 gene, led to apoptotic cell death. Moreover, breast cancer cell lines and patient tumours display a coordinate loss of p53 and HOXA5 mRNA and protein expression. The HOXA5 promoter region was methylated in 16 out of 20 p53-negative breast tumour specimens. We conclude that loss of expression of p53 in human breast cancer may be primarily due to lack of expression of HOXA5.",
author = "Venu Raman and Martenser, {Shelby A.} and David Reisman and Ella Evron and Odenwald, {Wart F.} and Elizabeth Jaffee and Jeffrey Marks and Saraswati Sukumar",
year = "2000",
month = "6",
day = "22",
doi = "10.1038/35016125",
language = "English (US)",
volume = "405",
pages = "974--978",
journal = "Nature",
issn = "0028-0836",
publisher = "Nature Publishing Group",
number = "6789",

}

TY - JOUR

T1 - Compromised HOXA5 function can limit p53 expression in human breast tumours

AU - Raman, Venu

AU - Martenser, Shelby A.

AU - Reisman, David

AU - Evron, Ella

AU - Odenwald, Wart F.

AU - Jaffee, Elizabeth

AU - Marks, Jeffrey

AU - Sukumar, Saraswati

PY - 2000/6/22

Y1 - 2000/6/22

N2 - Expression of the p55 gene protects cells against malignant transformation. Whereas control of p53 degradation has been a subject of intense scrutiny, little is known about the factors that regulate p53 synthesis. Here we show that p53 messenger RNA levels are low in a large proportion of breast tumours. Seeking potential regulators of p53 transcription, we found consensus HOX binding sites in the p53 promoter. Transient transfection of Hox/HOXA5 activated the p53 promoter. Expression of HOXA5 in epithelial cancer cells expressing wild-type p53, but not in isogenic variants lacking the p53 gene, led to apoptotic cell death. Moreover, breast cancer cell lines and patient tumours display a coordinate loss of p53 and HOXA5 mRNA and protein expression. The HOXA5 promoter region was methylated in 16 out of 20 p53-negative breast tumour specimens. We conclude that loss of expression of p53 in human breast cancer may be primarily due to lack of expression of HOXA5.

AB - Expression of the p55 gene protects cells against malignant transformation. Whereas control of p53 degradation has been a subject of intense scrutiny, little is known about the factors that regulate p53 synthesis. Here we show that p53 messenger RNA levels are low in a large proportion of breast tumours. Seeking potential regulators of p53 transcription, we found consensus HOX binding sites in the p53 promoter. Transient transfection of Hox/HOXA5 activated the p53 promoter. Expression of HOXA5 in epithelial cancer cells expressing wild-type p53, but not in isogenic variants lacking the p53 gene, led to apoptotic cell death. Moreover, breast cancer cell lines and patient tumours display a coordinate loss of p53 and HOXA5 mRNA and protein expression. The HOXA5 promoter region was methylated in 16 out of 20 p53-negative breast tumour specimens. We conclude that loss of expression of p53 in human breast cancer may be primarily due to lack of expression of HOXA5.

UR - http://www.scopus.com/inward/record.url?scp=0034702232&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034702232&partnerID=8YFLogxK

U2 - 10.1038/35016125

DO - 10.1038/35016125

M3 - Article

VL - 405

SP - 974

EP - 978

JO - Nature

JF - Nature

SN - 0028-0836

IS - 6789

ER -